Pulmonary vascular structure and function in chronic obstructive pulmonary disease - PubMed (original) (raw)
Pulmonary vascular structure and function in chronic obstructive pulmonary disease
F Magee et al. Thorax. 1988 Mar.
Abstract
Cardiac catheterization data from eight patients with severe chronic obstructive lung disease and pulmonary hypertension at rest (greater than 25 mm Hg) were compared with those obtained from 14 patients with mild to moderate disease whose pulmonary artery pressure was within the normal range at rest (mean 15 (SEM 1) mm Hg), but increased with exercise (30 (2) mm Hg). We obtained lung sections from necropsy material from the group with severe disease, and from surgical specimens in the group with mild to moderate disease, and compared the structure of the vasculature in these groups with that obtained from surgical specimens in a non-smoking control group of seven patients. Oxygen administration either at rest or during exercise did not greatly affect the pulmonary arterial pressures. When cardiac index was plotted against pulmonary artery pressure at rest and during exercise and extrapolated to the axis there was no evidence for a critical closing pressure in either group. The vessels in the groups with mild to moderate and severe chronic obstructive lung disease showed intimal thickening (each 19% (SD 0.5%)) by comparison with the non-smoking group (16% (0.5%]. The group with severe disease, in addition, had medial hypertrophy (27% (0.5%) versus 24% (SD 1%) in the non-smoking group). These data are consistent with the idea that the diseased vessels are distorted and rigid. The lack of effect of breathing oxygen on the vascular response at rest and during exercise suggests that hypoxic vasoconstriction has a minimal role in the pulmonary hypertension of chronic obstructive lung disease. The data suggest that the intimal changes could narrow the vessel calibre in those patients with mild to moderate disease, and that the thickened media present in the vessels from patients with severe disease may act in concert with the enlarged intima to produce more severe vascular obstruction.
Similar articles
- The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise.
Wright JL, Lawson L, Paré PD, Hooper RO, Peretz DI, Nelems JM, Schulzer M, Hogg JC. Wright JL, et al. Am Rev Respir Dis. 1983 Oct;128(4):702-7. doi: 10.1164/arrd.1983.128.4.702. Am Rev Respir Dis. 1983. PMID: 6625346 - "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease.
Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducoloné A, Ehrhart M, Oswald-Mammosser M. Kessler R, et al. Am J Respir Crit Care Med. 2001 Jul 15;164(2):219-24. doi: 10.1164/ajrccm.164.2.2006129. Am J Respir Crit Care Med. 2001. PMID: 11463591 - Pulmonary hypertension in chronic lung diseases.
Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Seeger W, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review. - Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Mal H. Mal H. Curr Opin Pulm Med. 2007 Mar;13(2):114-9. doi: 10.1097/MCP.0b013e32801d217f. Curr Opin Pulm Med. 2007. PMID: 17255801 Review.
Cited by
- Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction.
Cheyne WS, Williams AM, Harper MI, Eves ND. Cheyne WS, et al. Am J Physiol Heart Circ Physiol. 2016 Dec 1;311(6):H1367-H1374. doi: 10.1152/ajpheart.00458.2016. Epub 2016 Oct 7. Am J Physiol Heart Circ Physiol. 2016. PMID: 27765746 Free PMC article. - Changes in ventilation-perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling.
Hajian B, De Backer J, Vos W, van Geffen WH, De Winter P, Usmani O, Cahn T, Kerstjens HA, Pistolesi M, De Backer W. Hajian B, et al. Int J Chron Obstruct Pulmon Dis. 2018 Mar 6;13:833-842. doi: 10.2147/COPD.S153295. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29563783 Free PMC article. Clinical Trial. - Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism.
Peng W, Hucks D, Priest RM, Kan YM, Ward JP. Peng W, et al. Br J Pharmacol. 1996 Nov;119(5):1063-71. doi: 10.1111/j.1476-5381.1996.tb15778.x. Br J Pharmacol. 1996. PMID: 8922759 Free PMC article. - The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.
Mohsenin V. Mohsenin V. Sleep Breath. 2016 Sep;20(3):1059-67. doi: 10.1007/s11325-016-1351-y. Epub 2016 May 7. Sleep Breath. 2016. PMID: 27154628 Review. - Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.
Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, Hoffman E, Fessler HE, Criner GJ, Marchetti N, Scharf SM, Martinez FJ, Reilly JJ, Hatabu H; National Emphysema Treatment Trial Research Group. Matsuoka S, et al. Am J Respir Crit Care Med. 2010 Feb 1;181(3):218-25. doi: 10.1164/rccm.200908-1189OC. Epub 2009 Oct 29. Am J Respir Crit Care Med. 2010. PMID: 19875683 Free PMC article. Clinical Trial.
References
- J Appl Physiol. 1967 Nov;23(5):631-40 - PubMed
- Hum Pathol. 1970 Jun;1(2):215-26 - PubMed
- Scand J Respir Dis Suppl. 1971;77:77-81 - PubMed
- Am Rev Respir Dis. 1983 Oct;128(4):702-7 - PubMed
- Br J Dis Chest. 1984 Jul;78(3):211-6 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources